Pfizer Other Non-Current Liabilities 2010-2024 | PFE

Pfizer other non-current liabilities for the quarter ending September 30, 2024 were $22.627B, a 5.46% increase year-over-year.

  • Pfizer other non-current liabilities for 2023 were $25.073B, a 9.05% increase from 2022.
  • Pfizer other non-current liabilities for 2022 were $22.992B, a 9.1% increase from 2021.
  • Pfizer other non-current liabilities for 2021 were $21.074B, a 15.61% increase from 2020.

Pfizer Other Non-Current Liabilities 2010-2024 | PFE

  • Pfizer other non-current liabilities for 2023 were $25.073B, a 9.05% increase from 2022.
  • Pfizer other non-current liabilities for 2022 were $22.992B, a 9.1% increase from 2021.
  • Pfizer other non-current liabilities for 2021 were $21.074B, a 15.61% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B